Top

Published in:

Open Access 01-12-2010 | Review

Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology

Authors: Céline Bourgier, Mahmut Ozsahin, David Azria

Published in: Radiation Oncology | Issue 1/2010

Abstract

Early breast cancer treatment is based on a multimodality approach with the application of clinical and histological prognostic factors to determine locoregional and systemic treatments. The entire scientific community is strongly involved in the management of this disease: radiologists for screening and early diagnosis, gynecologists, surgical oncologists and radiation oncologists for locoregional treatment, pathologists and biologists for personalized characterization, genetic counselors for BRCA mutation history and medical oncologists for systemic therapies.

Recently, new biological tools have established various prognostic subsets of breast cancer and developed predictive markers for miscellaneous treatments.

The aim of this article is to highlight the contribution of biological tools in the locoregional management of early breast cancer.

Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinie F, Danzon A, Bara S, Bouvier AM, Tretarre B, Binder-Foucard F, Colonna M, Daubisse L, Hedelin G, Launoy G, Le Stang N, Maynadie M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Cherie-Challine L, Esteve J, Remontet L, Velten M: Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56: 159-75. 10.1016/j.respe.2008.03.117CrossRefPubMed

Perou CM, Sorlie T, Eisen MB, Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D: Molecular portraits of human breast tumours. Nature 2000, 406: 747-52. 10.1038/35021093CrossRefPubMed

Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borresen-Dale AL: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98: 10869-74. 10.1073/pnas.191367098PubMedCentralCrossRefPubMed

van 't Veer LJ, Dai H, Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415: 530-6. 10.1038/415530aCrossRefPubMed

Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351: 2817-26. 10.1056/NEJMoa041588CrossRefPubMed

Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365: 671-9.CrossRefPubMed

Chang HY, Nuyten DS, Sneddon JB, Hastie T, Tibshirani R, Sorlie T, Dai H, He YD, van't Veer LJ, Bartelink H, Rijn M, Brown PO, Vijver MJ: Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 2005, 102: 3738-43. 10.1073/pnas.0409462102PubMedCentralCrossRefPubMed

Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007, 356: 217-26. 10.1056/NEJMoa063994CrossRefPubMed

van Beers EH, Nederlof PM: Array-CGH and breast cancer. Breast Cancer Res 2006, 8: 210. 10.1186/bcr1510PubMedCentralCrossRefPubMed

10.

Andre F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, Vielh P, Delaloge S: Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Lancet Oncol 2009, 10: 381-90. 10.1016/S1470-2045(09)70024-5CrossRefPubMed

11.

Bueno-de-Mesquita JM, van Harten WH, Retel VP, van't Veer LJ, van Dam FS, Karsenberg K, Douma KF, van Tinteren H, Peterse JL, Wesseling J, Wu TS, Atsma D, Rutgers EJ, Brink G, Floore AN, Glas AM, Roumen RM, Bellot FE, van Krimpen C, Rodenhuis S, Vijver MJ, Linn SC: Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol 2007, 8: 1079-87. 10.1016/S1470-2045(07)70346-7CrossRefPubMed

12.

Delaloge S, Noel E, Andre F, Benhamou E, Larue C, Balleyguier C, Vielh P, de Pouvourville G: Medico-economic evaluation of the rapid diagnosis of breast lesions using fine-needle aspiration in a one stop breast clinic (Abstr. 3040). Breast Cancer Research and Treatment 2007.,106(Supplement 1):

13.

Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L: Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 2003, 97: 2960-71. 10.1002/cncr.11435CrossRefPubMed

14.

Uzan C, Andre F, Scott V, Laurent I, Azria E, Suciu V, Balleyguier C, Lacroix L, Delaloge S, Vielh P: Fine-needle aspiration for nucleic acid-ased molecular analyses in breast cancer. Cancer Cytopathol 2009, 117: 32-9. 10.1002/cncy.20008CrossRef

15.

Meunier M, Clough K: Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesions. Eur J Radiol 2002, 42: 10-6. 10.1016/S0720-048X(01)00480-6CrossRefPubMed

16.

Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, Di Leo A: Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer. Breast Cancer Res 2009, 11: 205. 10.1186/bcr2238PubMedCentralCrossRefPubMed

17.

Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 2007, 18: 1133-44. 10.1093/annonc/mdm271CrossRefPubMed

18.

Viale G, Giobbie-Hurder A, Regan MM, Coates AS, Mastropasqua MG, Dell'Orto P, Maiorano E, MacGrogan G, Braye SG, Ohlschlegel C, Neven P, Orosz Z, Olszewski WP, Knox F, Thurlimann B, Price KN, Castiglione-Gertsch M, Gelber RD, Gusterson BA, Goldhirsch A: Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol 2008, 26: 5569-75. 10.1200/JCO.2008.17.0829PubMedCentralCrossRefPubMed

19.

Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang YM: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366: 2087-106.CrossRefPubMed

20.

Bartelink H, Horiot JC, Poortmans P, Struikmans H, Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 2001, 345: 1378-87. 10.1056/NEJMoa010874CrossRefPubMed

21.

Dilhuydy JM, Bussieres E, Romestaing P: [Radiotherapy of the breast and chest wall: treatment volume]. Cancer Radiother 2001, 5: 550-9.CrossRefPubMed

22.

Fernando IN, Ford HT, Powles TJ, Ashley S, Glees JP, Torr M, Grafton D, Harmer CL: Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 1996, 8: 226-33.CrossRef

23.

Azria D, Rat F, Huguet H, Lemanski C, Llacer Moscardo C, Kerr C, Hay M, Dubois JB: Postmastectomy Radiotherapy in Intermediate-risk Patients: Long Term Carcinologic and Quality of Life Results of the Montpellier Cancer Center. Int J Radiat Oncol Biol Phys 2009, 75.

24.

Vicini FA, Kestin L, Huang R, Martinez A: Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 2003, 97: 910-9. 10.1002/cncr.11143CrossRefPubMed

25.

Elkhuizen PH, Vijver MJ, Hermans J, Zonderland HM, Velde CJ, Leer JW: Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998, 40: 859-67. 10.1016/S0360-3016(97)00917-6CrossRefPubMed

26.

Arriagada R, Le MG, Contesso G, Guinebretiere JM, Rochard F, Spielmann M: Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002, 13: 1404-13. 10.1093/annonc/mdf227CrossRefPubMed

27.

Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T: Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 2003, 14: 1617-22. 10.1093/annonc/mdg452CrossRefPubMed

28.

Huston TL, Simmons RM: Locally recurrent breast cancer after conservation therapy. Am J Surg 2005, 189: 229-35. 10.1016/j.amjsurg.2004.07.039CrossRefPubMed

29.

Clarke DH, Le MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, May-Levin F, Contesso G, Arriagada R: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 1985, 11: 137-45. 10.1016/0360-3016(85)90372-4CrossRefPubMed

30.

Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991, 338: 327-31. 10.1016/0140-6736(91)90475-5CrossRefPubMed

31.

Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW: Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 1989, 76: 890-4. 10.1002/bjs.1800760906CrossRefPubMed

32.

Truong PT, Lesperance ML, Sanghani M, Jones H, Tighouart H, Wazer D, Olivotto IA: Independent Validation of IBTR! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery. Int J Radiat Oncol Biol Phys 2008, 72:#203.

33.

Sanghani M, Raad RA, Niemierko A, Taghian A, Wazer D: Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy. Int J Radiat Oncol Biol Phys 2008, 72: S91.CrossRef

34.

Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 2008, 26: 2373-8. 10.1200/JCO.2007.14.4287CrossRefPubMed

35.

Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse H, Bartelink H, Brown PO, Chang HY, Vijver MJ: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 2006, 8: R62. 10.1186/bcr1614PubMedCentralCrossRefPubMed

36.

Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA: BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 1998, 281: 1009-12. 10.1126/science.281.5379.1009CrossRefPubMed

37.

Hanawalt PC: Transcription-coupled repair and human disease. Science 1994, 266: 1957-8. 10.1126/science.7801121CrossRefPubMed

38.

Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X: Low expression of bcl-2 in Brca1-associated breast cancers. Br J Cancer 2000, 83: 1318-22. 10.1054/bjoc.2000.1438PubMedCentralCrossRefPubMed

39.

Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, Isaacs C, Merajver SD, Wong JS, Garber JE, Weber BL: Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol 2006, 24: 2437-43. 10.1200/JCO.2005.02.7888CrossRefPubMed

40.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A: Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy. Eur J Cancer 2005, 41: 2304-11. 10.1016/j.ejca.2005.02.037CrossRefPubMed

41.

Liang K, Lu Y, Jin W, Ang KK, Milas L, Fan Z: Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2003, 2: 1113-20.PubMed

42.

Pietras RJ, Poen JC, Gallardo D, Wongvipat PN, Lee HJ, Slamon DJ: Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res 1999, 59: 1347-55.PubMed

43.

Horton JK, Halle J, Ferraro M, Carey L, Moore DT, Ollila D, Sartor CI: Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer with Trastuzumab: A Phase II Trial. Int J Radiat Oncol Biol Phys 2009, in press.

44.

Collette S, Collette L, Budiharto T, Horiot JC, Poortmans PM, Struikmans H, Bogaert W, Fourquet A, Jager JJ, Hoogenraad W, Mueller RP, Kurtz J, Morgan DA, Dubois JB, Salamon E, Mirimanoff R, Bolla M, Hulst M, Warlam-Rodenhuis CC, Bartelink H: Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. Eur J Cancer 2008, 44: 2587-99. 10.1016/j.ejca.2008.07.032CrossRefPubMed

45.

Ozsahin M, Ozsahin H, Shi Y, Larsson B, Wurgler FE, Crompton NE: Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 1997, 38: 429-40. 10.1016/S0360-3016(97)00038-2CrossRefPubMed

46.

Crompton NE, Shi YQ, Emery GC, Wisser L, Blattmann H, Maier A, Li L, Schindler D, Ozsahin H, Ozsahin M: Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 2001, 49: 547-54. 10.1016/S0360-3016(00)01477-2CrossRefPubMed

47.

Slonina D, Gasinska A: Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 1997, 72: 693-701. 10.1080/095530097142852CrossRefPubMed

48.

Azria D, Ozsahin M, Kramar A, Peters S, Atencio DP, Crompton NE, Mornex F, Pelegrin A, Dubois JB, Mirimanoff RO, Rosenstein BS: Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008, 14: 6284-8. 10.1158/1078-0432.CCR-08-0700PubMedCentralCrossRefPubMed

49.

Ozsahin M, Crompton NE, Gourgou S, Kramar A, Li L, Shi Y, Sozzi WJ, Zouhair A, Mirimanoff RO, Azria D: CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 2005, 11: 7426-33. 10.1158/1078-0432.CCR-04-2634CrossRefPubMed

Title: Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology
Authors: Céline Bourgier
Mahmut Ozsahin
David Azria
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Radiation Oncology / Issue 1/2010
Electronic ISSN: 1748-717X
DOI: https://doi.org/10.1186/1748-717X-5-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study

Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets

Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy

Effects of osteopontin inhibition on radiosensitivityof MDA-MB-231 breast cancer cells